Ken Fisher's DNLI Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 2.44 M shares of Denali Therapeutics Inc. (DNLI) worth $46.79 M, representing 0.02% of the portfolio. First purchased in 2024-Q1, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Ken Fisher has maintained a strategic position in DNLI, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 957,907 shares. Largest reduction occurred in Q1 2026, reducing 152,508 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Denali Therapeutics (DNLI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Denali Therapeutics (DNLI) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -152,508 | Reduce 5.89% | 2.44 M | $19.20 |
| Q4 2025 | +957,907 | Add 58.71% | 2.59 M | $16.51 |
| Q3 2025 | +115,505 | Add 7.62% | 1.63 M | $14.52 |
| Q2 2025 | +151,032 | Add 11.06% | 1.52 M | $13.99 |
| Q1 2025 | +572,460 | Add 72.23% | 1.36 M | $13.60 |
| Q4 2024 | +245,168 | Add 44.79% | 792,499 | $20.38 |
| Q3 2024 | +69,223 | Add 14.48% | 547,331 | $29.13 |
| Q2 2024 | +8,939 | Add 1.91% | 478,108 | $23.22 |
| Q1 2024 | +469,169 | New Buy | 469,169 | $20.52 |
Ken Fisher's Denali Therapeutics Investment FAQs
Ken Fisher first purchased Denali Therapeutics Inc. (DNLI) in Q1 2024, acquiring 469,169 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Denali Therapeutics Inc. (DNLI) for 9 quarters since Q1 2024.
Ken Fisher's largest addition to Denali Therapeutics Inc. (DNLI) was in Q4 2025, adding 2,589,403 shares worth $42.75 M.
According to the latest 13F filing for Q1 2026, Ken Fisher's firm, Fisher Asset Management, LLC, owns 2,436,895 shares of Denali Therapeutics Inc. (DNLI), valued at approximately $46.79 M.
As of the Q1 2026 filing, Denali Therapeutics Inc. (DNLI) represents approximately 0.02% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Denali Therapeutics Inc. (DNLI) was 2,589,403 shares, as reported at the end of Q4 2025.